MMC vs PLSE · P/E 22, rev $24.46B vs rev $835.0K
Marsh & McLennan Companies Inc (MMC) versus Pulse Biosciences Inc (PLSE) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Pulse Biosciences Inc (PLSE) is a medical instruments & supplies company listed on US.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Latest reported PLSE revenue for 2026-06-30 was $835.0K. Net income was -$43.2M. PLSE currently screens at market cap $1.03B.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. PLSE currently screens at market cap $1.03B.
Not investment advice. Open the MMC and PLSE stock pages for the full models.
Not investment advice.